Momenta Pharmaceuticals, Inc. (MNTA)

[investorgold2002]

FOB-survey results

2013 -biosimilar
2016 -biogeneric

I guess is it possible that MNTA could file biosimilar application and get it approved as biosimilar (since it is a tall order to prove substitutability?) and then convert/file the same drug under a biogeneric application later ?

http://investorshub.advfn.com/boards/board_survey_results.asp?board_id=1418&Survey_Num=139